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ABSTRACT
ObjeCtives
To determine if coronary computed tomographic 
angiography enhances prediction of perioperative risk 
in patients before non-cardiac surgery and to assess 
the preoperative coronary anatomy in patients who 
experience a myocardial infarction after non-cardiac 
surgery.
Design
Prospective cohort study.
setting
12 centers in eight countries.
PartiCiPants
955 patients with, or at risk of, atherosclerotic disease 
who underwent non-cardiac surgery.
interventiOns
Coronary computed tomographic angiography was 
performed preoperatively; clinicians were blinded to 
the results unless left main disease was suspected. 
Results were classified as normal, non-obstructive 
(<50% stenosis), obstructive (one or two vessels with 
≥50% stenosis), or extensive obstructive (≥50% 
stenosis in two vessels including the proximal left 
anterior descending artery, three vessels, or left main).
Main OutCOMe Measure
Composite of cardiovascular death and non-fatal 
myocardial infarction within 30 days after surgery 
(primary outcome). This was the dependent variable in 
Cox regression. The independent variables were scores 
on the revised cardiac risk index and findings on 
coronary computed tomographic angiography.
results
The primary outcome occurred in 74 patients (8%). The 
model that included both scores on the revised cardiac 
risk index and findings on coronary computed 
tomographic angiography showed that coronary 
computed tomographic angiography provided 
independent prognostic information (P=0.014; 
C index=0.66). The adjusted hazard ratios were 1.51 (95% 
confidence interval 0.45 to 5.10) for non-obstructive 
disease; 2.05 (0.62 to 6.74) for obstructive disease; and 
3.76 (1.12 to 12.62) for extensive obstructive disease. For 
the model with coronary computed tomographic 
angiography compared with the model based on the 
revised cardiac risk index alone, with 30 day risk 
categories of <5%, 5-15%, and >15% for the primary 
outcome, the results of risk reclassification indicate that 
in a sample of 1000 patients that coronary computed 
tomographic angiography would have resulted 
appropriately in 17 net patients receiving a higher risk 
estimation among the 77 patients who would have 
experienced the primary outcome (P<0.001). Coronary 
computed tomographic angiography, however, would 
have resulted inappropriately in 98 net patients 
receiving a higher risk estimation, among the 923 
patients who would not have experienced the primary 
outcome (P<0.001). Among patients who had a 
perioperative myocardial infarction, preoperative 
coronary anatomy showed extensive obstructive disease 
in 31% (22/71), obstructive disease in 41% (29/71), 
non-obstructive disease in 24% (17/71), and normal 
findings in 4% (3/71).
COnClusiOns
Though findings on coronary computed tomographic 
angiography can improve estimation of risk for 
patients who will experience perioperative 
cardiovascular death or myocardial infarction, findings 
are more than five times as likely to lead to an 
inappropriate overestimation of risk among patients 
What is already knoWn on this topic
Clinical risk prediction models provide suboptimal prediction of risk of 
perioperative cardiac complications
The incremental risk prediction of imaging tests is uncertain because of limited 
availability of high quality evidence
Prognosis is poor for myocardial infarction after non-cardiac surgery, but there is 
limited knowledge regarding the degree of coronary artery stenosis in patients who 
have a perioperative myocardial infarction
What this study adds
Compared with the revised cardiac risk index alone, findings on preoperative 
coronary computed tomographic angiography will appropriately improve risk 
estimation among patients who will experience perioperative cardiovascular death 
or a myocardial infarction but will inappropriately result in overestimation of risk 
among patients who will not experience these outcomes within 30 days of 
non-cardiac surgery
With 30 day risk categories of <5%, 5-15%, and >15% for the primary outcome, the net 
absolute effect in a sample of 1000 patients is that coronary computed tomographic 
angiography will result in an inappropriate estimate of risk in 81 patients compared 
with risk estimation based on the revised cardiac risk index alone.
Perioperative myocardial infarction occurs in patients with and without 
preoperative obstructive coronary artery disease on preoperative coronary 
computed tomographic angiography
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who will not experience these outcomes. Perioperative 
myocardial infarction occurs across the spectrum of 
coronary artery disease, suggesting that there could be 
several pathophysiologic mechanisms.
Introduction
Although major cardiac complications after non- 
cardiac surgery are common,1  our capacity to predict 
these events in individual patients is limited.2  The abil-
ity to identify an increased risk of perioperative isch-
emic events could influence the type of operation 
performed or inform the decision whether to proceed 
with intervention or manage conservatively. Alterna-
tively, patients with an anticipated low risk are likely to 
be operated on safely without delay.3  Clinical practice 
guidelines recommend assessment of preoperative risk, 
beginning with clinical risk indices.3  4  Clinical risk indi-
ces, however, underestimate the risk of major perioper-
ative complications, particularly in patients with 
limited mobility before surgery.5  It might, therefore, be 
worth using a supplemental method to enhance risk 
prediction. Though myocardial infarction is the most 
common major perioperative cardiac complication, lit-
tle is known about its pathophysiology.2
Coronary computed tomographic angiography is a 
non-invasive method for the detection of coronary 
artery disease. In contrast with stress nuclear and stress 
echocardiography imaging, which detect areas of isch-
emic myocardium, coronary computed tomographic 
angiography identifies the presence and distribution of 
coronary plaque and stenoses. In patients with stable 
angina, the extent of coronary artery disease shown on 
coronary computed tomographic angiography can pre-
dict the occurrence of major cardiac events.6-8 Its value 
in enhancing risk prediction among patients undergo-
ing non-cardiac surgery, however, is unknown.
We conducted this study (the coronary computed 
tomographic angiography vascular events in non- 
cardiac surgery patients cohort evaluation (Coronary 
CTA VISION)) to determine if preoperative coronary com-
puted tomographic angiography has additional predic-
tive value, beyond clinical variables, for cardiovascular 
death or non-fatal myocardial infarction within 30 days 
after surgery and the preoperative coronary anatomy 
associated with perioperative myocardial infarction.
Methods
study design and eligibility criteria
This was a prospective observational study. We have 
published details of the study objectives, design, and 
methods elsewhere.9
Patients were eligible if they fulfilled the following 
criteria: age ≥45; undergoing elective vascular, orthope-
dic, thoracic, or abdominal surgery in hospital; had 
sufficient time to undergo coronary computed tomo-
graphic angiography before surgery; and had a history 
of, or risk factors for, atherosclerotic disease or a history 
of congestive heart failure.
Patients fulfilling any of the following criteria were 
excluded: planned invasive coronary angiography for 
preoperative investigation before surgery; history of 
coronary artery stent implantation; creatinine clear-
ance <35 mL/min; known contrast reaction; current 
pregnancy; persistent atrial fibrillation or frequent pre-
mature beats; heart rate ≥70 beats/min (at centers with 
single source scanners) or ≥90 beats/min (at centers 
with dual source scanners), despite drugs to control 
heart rate just before scheduled coronary computed 
tomographic angiography; weight >300 lb (136 kg); 
more than four non-evaluable segments on coronary 
computed tomographic angiography (non-diagnostic 
scan); did not undergo non-cardiac surgery within six 
months after coronary computed tomographic angiog-
raphy; surgery that did not require at least an overnight 
stay in hospital; or results of coronary computed tomo-
graphic angiography were unblinded because of sus-
pected left main stenosis and patient underwent 
preoperative coronary revascularization.
Coronary computed tomographic angiography
The protocol we used for coronary computed tomo-
graphic angiography imaging is reported in appendix 1. 
A panel of expert evaluators (that is, a cardiologist or 
radiologist with level 3 training in interpretation of cor-
onary computed tomographic angiography) read each 
angiogram using a 17 segment model of the coronary 
arteries without knowledge of the clinical data.10  Each 
of scans was scored as normal—no evidence of coronary 
atherosclerosis; non-obstructive coronary artery dis-
ease—evidence of at least one coronary artery plaque 
with a <50% stenosis; obstructive coronary artery dis-
ease—at least one coronary artery plaque with a ≥50% 
stenosis; or extensive obstructive disease—≥50% steno-
sis in two coronary arteries including the proximal left 
anterior descending artery, ≥50% stenosis in three cor-
onary arteries, or ≥50% stenosis in the left main coro-
nary artery.9
Patients who had previously undergone coronary 
artery bypass grafting surgery were assessed for the 
number of unprotected coronary territories (bypass 
graft with ≥50% stenosis and native coronary artery 
with ≥50%).11 Patients with no or one unprotected coro-
nary territory were classified as having obstructive cor-
onary artery disease, and patients with two or three 
unprotected coronary territories were classified as hav-
ing extensive obstructive disease.
Patients with a ≥50% stenosis in the left main artery 
had the results of their coronary computed tomographic 
angiography reported immediately to their attending 
physicians. Potentially important incidental non-car-
diac findings were disclosed immediately after the scan 
was interpreted. All other patients had their results 
withheld from the attending clinical care team until 30 
days after surgery.
study procedures
Study personnel obtained data on patients’ characteris-
tics. All patients had scheduled troponin measure-
ments at six to 12 hours after surgery and on the first, 
second, and third days after surgery. An electrocardio-
gram was obtained immediately after an increased 
 troponin measurement was detected. 
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Study personnel followed patients throughout their 
hospital stay and reviewed their medical records 
ensuring study orders were followed and noting any 
outcomes (such as mortality). We contacted patients 
by phone 30 days after surgery. If patients or their next 
of kin indicated that they had experienced an outcome 
(that is, myocardial infarction or mortality) or had 
been admitted to hospital, study personnel obtained 
the appropriate documentation from the attending 
 clinicians.
Outcomes measures and definitions
Our primary outcome was a composite of cardiovascu-
lar death and non-fatal myocardial infarction within 30 
days after surgery. For the diagnosis of myocardial 
infarction we used the criteria of the universal defini-
tion of myocardial infarction12 that required a typical 
rise of troponin concentration associated with one of 
the following: ischemic signs or symptoms, ischemic 
changes on electrocardiography, or new imaging abnor-
malities suggestive of myocardial infarction. A panel of 
clinicians who were blinded to the results of coronary 
computed tomographic angiography adjudicated the 
outcomes of cardiovascular death and myocardial 
infarction. We used the adjudicated results for all statis-
tical analyses.
Patient involvement
We did not involve patients or lay people in the design 
of the study, selection of outcome measures, or recruit-
ment plans and do not plan to disseminate the results to 
the study participants.
statistical analyses
A priori, we determined that we needed 1000 patients 
to ensure a stable model if our primary event rate was 
6%.9 After we had 30 day outcomes for 950 patients, we 
determined that our event rate was >7.5% and that we 
had enough patients to assess whether coronary com-
puted tomographic angiography provided independent 
prognostic information beyond clinical variables. We 
therefore stopped recruitment without knowledge of 
the relation between the findings and the primary out-
come and subsequently undertook the analyses. The 
data monitoring committee reviewed the data when 
about 40% of the data and separately when 65% of the 
data on 30 day outcomes were available.
The operations committee prespecified the data 
analysis plan. Patients who did not complete 30 day 
 follow-up were censored on the last day that their vital 
status was known. We determined the percentage of 
patients who had a primary outcome event within 30 
days after surgery.
We undertook Cox proportional hazards modeling in 
which the dependent variable was cardiovascular 
death and non-fatal myocardial infarction. In the first 
model, the independent variable was the score on the 
revised cardiac index.13  This risk score is well validated, 
widely used, and recommended for clinical risk stratifi-
cation in recent guidelines.3 4  The model includes six 
variables: high risk surgery, history of coronary artery 
disease, history of heart failure, history of cerebrovas-
cular disease, preoperative treatment with insulin, and 
preoperative creatinine >170 mmol/L. The presence of 
each variable adds one point, and patients obtain 
scores from 0-6, with higher scores indicating greater 
risk.13
In the second model, the independent variable was 
findings on coronary computed tomographic angiogra-
phy (that is, non-obstructive, obstructive, and extensive 
obstructive with a reference category of normal coro-
nary arteries). The final model included both the clini-
cal risk scores on the revised cardiac risk index and 
findings of coronary computed tomographic angiogra-
phy as independent variables.
For all independent predictors of the primary out-
come, we determined the adjusted hazard ratio and 
the associated 95% confidence intervals. A two sided 
P value was designated a priori as significant at an α of 
0.05. Discrimination was assessed through evaluation 
of the C index. Likelihood ratios were determined for 
each category of findings on coronary computed tomo-
graphic angiography.
We performed post hoc sensitivity analyses to deter-
mine if the results were influenced by whether or not a 
patient had a history of prior vascular disease, had 
prior coronary artery disease, or had undergone vascu-
lar or orthopedic surgery. For these analyses, we used 
an interaction term in our models for each of these fac-
tors. We also undertook another post hoc subgroup 
analysis restricted to patients without a history of a 
prior coronary artery bypass grafting.
We calculated reclassification of risk among patients 
who experienced the primary outcome and separately 
among patients who did not experience the primary 
outcome to determine if findings on coronary computed 
tomographic angiography improved risk classification 
beyond that achieved with the revised cardiac risk 
index clinical model.14  In this analysis, we classified the 
30 day primary outcome as low risk <5%, intermediate 
risk 5-15%, and high risk >15%. We also performed a 
sensitivity analysis for the net improvement in reclassi-
fication that included four risk categories (<5%, 5-10%, 
≥10-15%, and ≥15%) and a post hoc evaluation of the 
risk categories recommended in the European Society 
of Cardiology guidelines (<1%, 1-5%, and >5%).3
We performed post hoc analyses to evaluate the prog-
nostic capabilities of coronary computed tomographic 
angiography using a ≥70% stenosis threshold to define 
obstructive coronary artery and extensive obstructive. 
We also performed post hoc analyses to evaluate the 
prognostic capabilities of coronary computed tomo-
graphic angiography in patients with one or two of the 
following: history of coronary artery disease, age >70, 
and diabetes requiring treatment.15 All analyses 
were  performed with SAS version 9.2 (SAS Institute, 
Cary, NC).
Results
Patients were recruited from 12 centers from July 2008 
to October 2013. Of the 1093 patients who under-
went preoperative coronary computed tomographic 
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 angiography, 1067 underwent a scan. We identified 14 
patients with suspected left main disease and 
unblinded their angiography results. Five of these 
patients had their non-cardiac surgery cancelled. 
A further 71 patients did not undergo surgery within 
six months for other reasons and were also excluded 
(fig 1). Of the remaining 991 patients, three were 
excluded because they had left main disease and 
underwent preoperative coronary revascularization 
and 33 were excluded because they had a non-diag-
nostic scan, outpatient surgery, or had concomitant 
coronary revascularization with non-cardiac surgery.
The 955 remaining eligible patients were enrolled 
and included in the study. We included six of the 14 
patients with suspected left main disease because these 
patients had non-cardiac surgery without preoperative 
coronary revascularization. Among the included 
patients, 99.5% completed the 30 day follow-up.
Table 1 shows characteristics of the patients and 
types of surgery. The mean age was 69.7 and 61% 
(584/955) were men. A history of known vascular dis-
ease was present in 61% (579/955) of patient, and 39% 
(376/955) of patients had three or more vascular risk fac-
tors without a history of known vascular disease. The 
most common score on the revised cardiac risk index 
was 1 (43%, 407/955), and 24% (228/955) of patients had 
a score ≥2. The most common types of surgery were 
orthopedic (56%, 538/955) and vascular (30%, 289/955).
Coronary computed tomographic angiography was 
performed with prospective triggering in 33% (319/955) 
of patients and with retrospective gating with x ray dose 
modulation in 53% (501/955). The mean contrast vol-
ume was 100.2 mL, and the mean radiation dose, mea-
sured as the dose length product, was 797.6 mGy-cm (or 
11.2 mSV).
Results of angiography showed that 81/955 patients 
(8%) had normal coronary arteries, 371/955 (39%) had 
non-obstructive coronary artery disease, 357/955 (37%) 
had obstructive coronary artery disease, and 146/955 
(15%) had extensive obstructive disease. The primary 
outcome (that is, cardiovascular death or myocardial 
infarction) occurred in 74/955 patients (8%), of whom 
eight (1%) experienced cardiovascular death and 71 
(7%) experienced a myocardial infarction. Fig 2 shows 
the Kaplan Meier curves for the primary outcome by 
findings on coronary computed tomographic angiogra-
phy. The primary outcome occurred in 3/81 patients 
(4%) with normal findings, 19/371 (5%) with non-ob-
structive coronary artery disease, 29/357 (8%) with 
obstructive coronary artery disease, and 23/146 (16%) 
with extensive obstructive disease. None of the six 
patients with suspected left main stenosis, who 
underwent non-cardiac surgery without preoperative 
revascularization, experienced the primary outcome. 
Kaplan Meier curves for cardiovascular death and myo-
cardial infarction separately are reported figs A and B 
in appendix 2.
Table 2 shows the models to predict 30 day cardio-
vascular death and myocardial infarction. In the model 
with scores on the revised cardiac risk index as the 
only independent variables, the C index was 0.62 (95% 
confidence interval 0.56 to 0.68). A score ≥3 compared 
with a score of 0 had a hazard ratio of 5.25 (95% confi-
dence interval 2.41 to 11.43). In the model with findings 
on coronary computed tomographic angiography as 
the only independent variables, the C index was 0.62 
(0.56 to 0.68). Extensive obstructive coronary artery 
disease compared with normal findings resulted in a 
hazard ratio of 4.50 (1.35 to 15.00). In the model that 
included both coronary computed tomographic angi-
ography and the revised cardiac risk index, the C index 
was 0.66 (0.60 to 0.73). In this model, that included 
scores on the revised cardiac risk index, extensive 
obstructive coronary artery disease had an adjusted 
hazard ratio of 3.76 (1.12 to 12.62). The likelihood ratios 
for findings on coronary computed tomographic angi-
ography are reported in table A in appendix 3. Exten-
sive obstructive disease had a likelihood ratio of 2.23 
(1.53 to 3.24).
The post hoc sensitivity analyses to determine if the 
ability of coronary computed tomographic angiography 
to provide independent prognostic information varied 
by subgroups showed no significant effect of a history 
of vascular disease (interaction P=0.984), a history of 
coronary artery disease (interaction P=0.327), or type of 
surgery (interaction P=0.325). For patients without prior 
coronary artery bypass grafting, the findings on coro-
nary computed tomographic angiography in our model 
that included scores on the revised cardiac risk index 
are shown in table B in appendix 3. The hazard ratio 
point estimates for the findings on coronary computed 
tomographic angiography in patients who did not 
undergo prior coronary artery bypass grafting were sim-
ilar to the results for the entire study population.
For the model that included the findings on coronary 
computed tomographic angiography compared with 
the model that included only the scores on the revised 
cardiac risk index, the reclassification of risk was 22% 
Underwent preoperative CCTA (n=1093)
Complete CCTA scan (n=1067)
Underwent surgery within 6 months of CCTA scan (n=991)
Eligible and included in study (n=955)
Incomplete CCTA scan (n=26)
Did not complete surgery within 6 months (n=76):
  Left main disease on CCTA scan (n=5)
  Non-coronary nding on CCTA scan (n=1)
  Reasons unrelated to CCTA results (n=70)
Excluded (n=36):
  Complete but non-diagnostic CCTA scan (n=29)
  Left main disease and underwent preoperative
    coronary revascularisation (n=3)
  Coronary revascularisation at time of non-cardiac
    surgery (n=1)
  Did not stay overnight in hospital (n=3)
Fig 1 | Flow of patients throughout study of prognostic 
capabilities of coronary computed tomographic 
angiography carried out before non-cardiac surgery 
(CCta=coronary computed tomographic angiography)
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(16/74; 95% confidence interval 10% to 33%; P<0.001) 
for those who experienced the primary outcome and 
−11% (−94/881; −14% to −7%; P<0.001) for those who 
did not experience the primary outcome (table 3). When 
we compared the model with coronary computed tomo-
graphic angiography with the model based on the 
revised cardiac risk index alone, using 30 day risk cate-
gories of <5%, 5-15%, and >15%, the results of risk reclas-
sification indicate that in a sample of 1000 patients that 
coronary computed tomographic angiography would 
have resulted appropriately in 17 net patients receiving a 
higher risk estimation, among the 77 patients who 
would have experienced the primary outcome (P<0.001); 
however, coronary computed tomographic angiography 
would have resulted inappropriately in 98 net patients 
receiving a higher risk estimation, among the 923 
patients who would not have experienced the primary 
outcome (P<0.001). The overall net effect in a sample of 
1000 patients would be that coronary computed tomo-
graphic angiography would result in an inappropriate 
table 1 | Characteristics of patients, risk factor profile, and type of surgery in study of prognostic capabilities of coronary 
computed tomographic angiography carried out before non-cardiac surgery. Figures are numbers (percentage) of 
patients unless stated otherwise
Demographics all patients (n=955)
Did not experience 
cardiovascular 
death or myocardial 
infarction (n=881)
experienced 
cardiovascular 
death or myocardial 
infarction (n=74)
Mean (SD) age (years) 69.7 (8.5) 69.5 (8.6) 72.2 (7.9)
Men 584 (61) 536 (61) 48 (65)
Mean (SD) BMI 30.0 (6.2) 30.1 (6.3) 28.6 (5.0)
Known vascular disease:
 History of CAD 305 (32) 267 (30) 38 (51)
 History of PVD 332 (35) 295 (33) 37 (50)
 History of stroke 88 (9) 78 (9) 10 (14)
 History of CHF 35 (4) 30 (3) 5 (7)
 Any of the above 579 (61) 518 (59) 61 (82)
Vascular risk factors:
 History of diabetes 362 (38) 328 (37) 34 (46)
 Age ≥70 512 (54) 464 (53) 48 (65)
 History of smoking within 2 years of surgery 257 (27) 239 (27) 18 (24)
 History of treatment for hypercholesterolemia 766 (80) 711 (81) 55 (74)
 History of TIA 91 (10) 83 (9) 8 (11)
 History of hypertension 838 (88) 770 (87) 68 (92)
  Patients qualified based on risk factors alone (that is, ≥3 of  
6 risk factors)
376 (39) 363 (41) 13 (18)
 Recent high risk CAD 8 (1) 6 (1) 2 (3)
 Myocardial infarction 1 1 0
 CCS II Angina 7 5 2
Patients with baseline:
 Stress nuclear imaging 90 (9) 78 (9) 12 (16)
 Stress echocardiography 7 (1) 7 (1) 0
Patient requires assistance with activities of daily living 40 (4) 36 (4) 5 (5)
Patients with baseline factors before operation:
 Statins <24h 457 (48) 424 (48) 33 (45)
 Statins >24h to 7 days 705 (74) 650 (74) 55 (74)
 β blocker <24h 294 (31) 263 (30) 31 (42)
 β blocker >24h to 7 days 369 (39) 326 (37) 43 (58)
Revised cardiac risk index score*:
 0 320 (34) 305 (35) 15 (20)
 1 407 (43) 378 (43) 29 (39)
 2 178 (19) 159 (18) 19 (26)
 3 43 (5) 33 (4) 10 (14)
 4 6 (1) 6 (1) 0
 5 1 (<1) 0 1 (1)
 6 0 0 0
Type of surgery:
 Vascular 289 (30) 259 (29) 30 (41)
 Intra-abdominal 72 (8) 67 (8) 5 (7)
 Orthopedic 538 (56) 502 (57) 36 (49)
 Major spine 13 (1) 13 (1) 0
 Other 53(6) 49 (6) 4 (5)
CAD=coronary artery disease; PVD=peripheral vascular disease; CHF=congestive heart failure; TIA=transient ischemic attack.
*Equally weighted clinical risk model including high risk surgery, history of coronary artery disease, history of heart failure, history of cerebrovascular 
disease, preoperative treatment with insulin, and preoperative creatinine >170 mmol/L.
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estimate of risk in 81 patients compared with risk esti-
mation based on the revised cardiac risk index alone.
The sensitivity analysis with four categories of risk 
suggested that the net effect in a sample of 1000 
patients would be that coronary computed tomo-
graphic angiography would result in a net inappropri-
ate estimate of risk in 22 patients compared with risk 
estimation based on the revised cardiac risk index 
alone (table C in appendix 3). Table D in appendix 3 
reports the post hoc risk reclassification analyses for 
the risk categories proposed in the European Society of 
Cardiology guidelines (<1%, 1-5%, and >5%).3 The find-
ings were similar to those of our a priori primary risk 
categories.
Table E in appendix 3 reports the post hoc sensitivity 
analysis evaluating the impact of using ≥70% stenosis 
to define obstructive and extensive obstructive coronary 
artery disease. The associated post hoc sensitivity anal-
ysis for the risk reclassification indicates that in a sam-
ple of 1000 patients, coronary computed tomographic 
angiography would result in a net overall inappropriate 
estimate of risk in 34 patients compared with risk esti-
mation based on the revised cardiac risk index alone 
(table F in appendix 3). Table G in appendix 3 reports 
the post hoc risk reclassification analyses that included 
only patients with one or two of the following risk fac-
tors: history of coronary artery disease, age >70, diabe-
tes requiring treatment. The risk reclassification in 
those with an event was 20.4% (P<0.001) and in those 
without an event was −12.4% (P<0.001). These results 
were therefore similar to the overall study.
Among patients experiencing a myocardial infarc-
tion, preoperative coronary computed tomographic 
angiography imaging showed extensive obstructive dis-
ease in 31% (22/71), obstructive disease in 41% (29/71), 
non-obstructive disease in 24% (17/71), and normal 
results in 4% (3/71) (see fig C in appendix 2).
Discussion
Principal findings
In this international prospective blinded cohort study of 
955 patients, multivariable analysis showed that 
 compared with the revised cardiac risk index alone, find-
ings on preoperative coronary computed tomographic 
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Normal
Non-obstructive
Obstructive
Extensive obstructive
Fig 2 | Findings on coronary computed tomographic 
angiography and survival free from cardiovascular death or 
myocardial infarction
table 2 | Models to predict 30 day cardiovascular death and myocardial infarction in study of prognostic capabilities of 
coronary computed tomographic angiography carried out before non-cardiac surgery
Model type
no of 
patients
no with 
event (%)
Hazard ratio 
(95% Ci) P value
revised cardiac risk index scores as only independent variables*
RCRI scores (overall P<0.001†):
 0 320 15 (4.7) 1.00 —
 1 407 29 (7.1) 1.53 (0.82 to 2.86) 0.178
 2 178 19 (10.7) 2.37 (1.20 to 4.66) 0.013
 ≥3 50 11 (22.0) 5.25 (2.41 to 11.43) <0.001
CCta findings as only independent variables*
CCTA findings (overall P<0.001‡):
 Normal 81 3 (3.7) 1.00 —
 Non-obstructive 371 19 (5.1) 1.40 (0.41 to 4.72) 0.590
 Obstructive 357 29 (8.1) 2.26 (0.69 to 7.41) 0.180
 Extensive obstructive 146 23 (15.8) 4.50 (1.35 to 15.00) 0.014
Combined CCta findings and revised cardiac risk index scores§
RCRI scores (overall P=0.005†):
 0 320 15 (4.7) 1.00 —
 1 407 29 (7.1) 1.39 (0.74 to 2.61) 0.300
 2 178 19 (10.7) 1.88 (0.94 to 3.79) 0.076
 ≥3 50 11 (22.0) 4.02 (1.80 to 8.98) <0.001
CCTA findings (overall P=0.014‡):
 Normal 81 3 (3.7) 1.00 —
 Non-obstructive 371 19 (5.1) 1.51 (0.45 to 5.10) 0.509
 Obstructive 357 29 (8.1) 2.05 (0.62 to 6.74) 0.238
 Extensive obstructive 146 23 (15.8) 3.76 (1.12 to 12.62) 0.032
CCTA=coronary computed tomographic angiography; RCRI=revised cardiac risk index.
*C=0.62, 95% confidence interval 0.56 to 0.68.
†Overall P value for four category RCRI.
‡Overall P value for four category CCTA.
§C=0.66, 95% confidence interval 0.60 to 0.73.
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 angiography can appropriately improve risk estimation 
among patients who will experience perioperative 
 cardiovascular death or have a myocardial infarction. 
Coronary computed tomographic angiography, how-
ever, is more than five times as likely to inappropriately 
overestimate risk among patients who will not experi-
ence cardiovascular death or a myocardial infarction 
within 30 days of non-cardiac surgery. Among patients 
who experienced myocardial infarction after surgery, we 
observed considerable variation in the extent of preop-
erative coronary artery disease.
strengths and limitations of our study
Our study has several methodological strengths. We 
enrolled a large number of patients with a wide spec-
trum of clinical risk at multiple centers. Our results are 
therefore likely to be widely generalisable. With the 
exception of suspected left main stenosis, all results 
from coronary computed tomographic angiography 
were blinded until 30 days after surgery. Primary out-
come events were adjudicated centrally by clinicians 
who were blinded to the angiographic findings. Clinical 
variables were prospectively ascertained and adjusted 
for in the multivariable analyses.
There were also, however, several limitations. We 
excluded patients who were likely to have technically 
suboptimal coronary computed tomographic angiogra-
phy examinations (for instance, patients with prior 
intracoronary stents, atrial fibrillation, or raised heart 
rates). Only a relatively small number of recruited 
patients had normal findings on coronary computed 
tomographic angiography. Consequently, estimation of 
the event rate in this group was imprecise. Although our 
study is one of the largest evaluations of perioperative 
imaging, it is possible with a larger study and more 
events that some of the findings on coronary computed 
tomographic angiography beyond extensive obstructive 
disease could have been independently associated with 
the primary outcome. The risk categories of <5%, 5-15%, 
and >15% for the primary outcome that we used to 
assess risk reclassification are arbitrary. These values 
were selected a priori because we believe they are val-
ues that physicians and patients consider important 
when regarding decisions around the appropriateness of 
surgery or requirements for enhanced perioperative mon-
itoring. These thresholds have been used in studies eval-
uating the prognostic capabilities of B-type natriuretic 
peptides to predict cardiovascular death and non-fatal 
myocardial infarction in patients undergoing non-car-
diac surgery.16  17 Moreover, sensitivity and post hoc 
analyses with other thresholds produced qualitatively 
similar findings.
Comparison with other modalities
In an effort to improve risk prediction in patients under-
going non-cardiac surgery, researchers have evaluated 
the prognostic capabilities of non-invasive cardiac 
stress tests.18  We hypothesized that coronary computed 
tomographic angiography could be advantageous for 
preoperative imaging because it does not require exer-
cise or pharmacologic stress and has high sensitivity for 
detection of coronary stenosis,19-21  including left main 
and multivessel coronary disease.22 In our study, the 
model with coronary computed tomographic angio-
graphic findings alone was able to predict the risk of 
cardiovascular death and myocardial infarction. The C 
index was 0.62, with a progressive increase in the esti-
mated hazard ratios with increasing burdens of coro-
nary artery disease. The hazard ratio, however, was 
significant only for extensive obstructive disease.
Although coronary computed tomographic angiogra-
phy is an anatomic imaging modality, there are import-
ant similarities between our results and those obtained 
in prior perioperative functional imaging studies with 
stress echocardiography and nuclear imaging.23 24  First, 
highly abnormal results that substantially increase esti-
mated risk were seen in a minority of patients (that is, 
we observed extensive obstructive disease in only 15% 
of patients). In a meta-analysis of preoperative imaging 
studies, moderate to severe abnormalities were seen in 
16% of stress echocardiogram tests and 15% of thallium 
imaging tests.23  Second, milder functional abnormali-
ties, while much more common, did not significantly 
increase risk. We observed a non-significant hazard 
ratio of 2.26 for obstructive coronary artery disease, 
a finding that was seen in 37% of patients. In a meta- 
analysis of preoperative nuclear imaging studies, <40% 
ischemic myocardium was seen in 34% of patients, with 
likelihood ratios ranging from 1.3 to 2.9.24  Third, in our 
study 28% of events occurred in patients without 
obstructive coronary artery disease. Similarly, it has 
been observed that preoperative nuclear abnormalities 
are absent in about 30% of patients who have a periop-
erative myocardial infarction.24
The results of our study differ from some prior periop-
erative imaging studies in that our estimated hazard 
ratios and C indices were lower. For example, in the 
only prior study of coronary computed tomographic 
angiography, 11 cardiovascular events occurred among 
the 37 patients who had multivessel disease (adjusted 
odds ratio 7.31, 95% confidence interval 2.25 to 23.69).25 
This study was, however, unblinded, retrospective, and 
did not include routine evaluation of postoperative car-
diac biomarkers to detect myocardial infarction. 
Although the investigators used a broad primary out-
come, they had only 19 events, putting the multivari-
able model at risk of an overfitted result.26 In contrast, 
we conducted a prospective blinded study that included 
table 3 | reclassification of risk (30 day probability of cardiovascular death and 
myocardial infarction) for those who did and did not experience primary outcome in 
model that included findings on coronary computed tomographic angiography (CCta) 
compared with model that included only revised cardiac risk index (rCri) scores*
rCri scores only
Model that included CCta findings
Patients who had an event Patients who did not have an event
<5% 5%-15% >15% <5% 5%-15% >15%
<5% 5 10 0 191 114 0
5%-15% 0 41 7 47 453 37
>15% 0 1 10 0 10 29
*CCTA risk reclassification for those who experienced primary outcome was: (17−1)/74=22%, 95% confidence 
interval 10% to 33%; P<0.001. Risk reclassification for those who did not experience primary outcome was: 
(57−151)/881=−11%, −14% to −7%; P<0.001.
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systematic monitoring of troponin measurements after 
surgery, and we had a more focused primary outcome 
(that is, cardiovascular death and myocardial infarc-
tion), and 71 of the 74 patients who experienced a pri-
mary outcome had a myocardial infarction.
Prior studies of preoperative functional imaging have 
shown that the presence of more extensive ischemia 
predicts a higher risk of perioperative events.23  24 Most 
of these studies were retrospective and did not have 
blinded evaluation of outcomes or routine screening for 
myocardial infarction. The confidence intervals on risk 
estimates associated with high risk findings were wide 
and overlapped between different modalities, showing 
that much larger comparative studies are required to 
determine if true differences exist between imaging 
techniques.
In contrast with the non-invasive imaging studies, 
several studies have shown that preoperative measure-
ment B-type natriuretic peptides in blood is a strong 
independent predictor of cardiovascular death and 
non-fatal myocardial infarction in patients undergoing 
non-cardiac surgery.16 17 Moreover, this blood test 
improves risk estimation both in patients who do and 
do not experience cardiovascular death or myocardial 
infarction.
Prediction beyond clinical variables
Imaging tests are expensive and usually require an 
additional visit to the clinic or hospital. Coronary com-
puted tomographic angiography and nuclear imaging 
also expose patients to contrast reaction and/or radia-
tion hazards. It is therefore important to establish that 
imaging tests can improve risk evaluation beyond clin-
ical variables. Most studies of preoperative imaging 
have not assessed whether non-invasive tests provide 
independent prognostic information, rather they have 
simply assessed the association between the imaging 
findings and the outcome without adjustment for the 
clinical information. The few studies that have assessed 
the independent prognostic information from imaging 
tests provide unreliable estimates because the analy-
ses had too few events for the number of variables 
assessed.27-31
In our study, we had 74 events and over 10 events per 
variable assessed in our model that combined scores on 
the revised cardiac risk index and findings of coronary 
computed tomographic angiography imaging. We 
found that findings on coronary computed tomographic 
angiography imaging independently affected risk 
 estimation. Although these angiographic findings 
improved risk estimation among patients who experi-
enced the primary event, they more commonly resulted 
in inappropriate overestimation of risk in patients who 
did not experience the primary outcome. This was also 
true for the results based on the post hoc analysis that 
evaluated the impact of using ≥70% stenosis to define 
obstructive and extensive obstructive coronary artery 
disease.
Overestimation of risk can have negative conse-
quences. It could lead to patients deciding against 
undergoing surgery because they view the risk as too 
high, when they would have accepted their actual risk. 
Clinicians might refer patients perceived to be at 
increased risk to invasive angiography and revascular-
ization, which would delay surgery and is of uncertain 
value in the perioperative period.32 There are limited 
resources for monitoring the highest risk patients after 
surgery, and if patients are inappropriately sent to a 
monitored bed because of an erroneous risk estimation 
this could preclude access for a patient who is actually 
genuinely at high risk.
A potential benefit of coronary computed tomo-
graphic angiography might be the ability to detect left 
main stenosis, which would likely prompt coronary 
revascularization before non-cardiac surgery.33 In our 
study, we identified 14 (1%) patients with suspected left 
main stenosis among 1067 who completed the coronary 
computed tomographic angiography scan, a detection 
rate that is possibly too low to justify routine such 
screening. Moreover, among the six patients with sus-
pected left main stenosis who underwent non-cardiac 
surgery without preoperative revascularization, none 
experienced the primary outcome.
There is value in identifying clinical contexts in 
which routine imaging screening does not provide an 
incremental benefit in risk prediction or outcomes. Our 
findings suggest that the resources that would be spent 
on preoperative coronary computed tomographic angi-
ography could be better utilized in other aspects of 
patient care. Similarly, a recent randomized controlled 
trial that evaluated coronary computed tomographic 
angiography screening in asymptomatic patients with 
diabetes showed no impact on cardiac events.34
Coronary anatomy associated with perioperative 
myocardial infarction
The pathophysiology of perioperative myocardial 
infarction remains controversial.2  Evaluation of coro-
nary angiograms from patients who have already expe-
rienced a perioperative myocardial infarction suggests 
that both thrombosis (type 1 myocardial infarction) and 
supply-demand mismatch (type 2 myocardial infarc-
tion) can play a role.35 36 These studies are limited by 
selection bias because patients with perioperative 
 myocardial infarction often do not undergo coronary 
angiography.
Our study provides complimentary angiographic 
data on a large sample of patients before surgery, show-
ing that 72% of patients who had a perioperative myo-
cardial infarction had either obstructive or extensive 
obstructive coronary artery disease visible on preopera-
tive coronary computed tomographic angiography. 
Patients with this pattern of coronary artery disease are 
at risk of type 1 and type 2 myocardial infarction. In con-
trast, no preoperative coronary stenosis ≥50% was seen 
in 28% of patients who experienced a perioperative 
myocardial infarction. In the absence of severe fixed 
coronary artery disease, mechanisms other than type 2 
myocardial infarction are likely implicated. Further 
investigations into the pathophysiology of periopera-
tive myocardial infarction and treatment interventions 
are needed.
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Conclusions
Compared with the revised cardiac risk index alone, 
findings on preoperative coronary computed tomo-
graphic angiographic will appropriately improve risk 
estimation among patients who will experience periop-
erative cardiovascular death or myocardial infarction 
but will inappropriately result in overestimation of risk 
among patients who will not experience such outcomes. 
With 30 day risk categories of <5%, 5-15%, and >15% for 
the primary outcome, the overall net effect in a sample 
of 1000 patients is that coronary computed tomographic 
angiography will result in an inappropriate estimate of 
risk in 81 patients compared with risk estimation based 
on the revised cardiac risk index alone. Perioperative 
myocardial infarction occurs across the spectrum of cor-
onary artery disease, suggesting the existence of multi-
ple pathophysiologic mechanisms.
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